TriSalus Life Sciences Inc. Common Stock (TLSI)
Stock · NASDAQ · Health Care
$3.65as of 10/16/2026
Price chart
TLSI Signal Track Record
How signals performed across all stocks →What TLSI's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 46 | +0.2% | 54% | September 18, 2026 |
| Bollinger Band Breakout | 27 | +0.2% | 59% | August 4, 2026 |
| Bollinger Band Breakdown | 15 | -6.2% | 33% | September 25, 2026 |
| 200-Day Moving Average TouchActive now | 16 | -4.3% | 44% | August 28, 2026 |
| Any 20-session window (baseline) | +0.3% | 55% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About TLSI
TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States. It offers Pressure-Enabled Drug Delivery (PEDD) infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization an…
- Sector
- Health Care
- Industry
- Medical Specialities
- Employees
- 102
- Website
- trisaluslifesci.com/
Fundamentals
- 1-day range
- $3.96$4.1
- Market cap
- $299.10M
- P/E (trailing)
- —
- P/E (forward)
- -15.84
- EPS (trailing)
- $-0.59
- Dividend yield
- —
- Beta
- 0.45
- Avg. volume
- 273.0K
How TriSalus Life Sciences Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 5, 2026 · via SEC EDGAR / Finnhub
Forecasts
5 analyst ratings
TriSalus Life Sciences Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- TLSITriSalus Life Sciences Inc. Common Stock$3.63▼ 6.92%Market cap $299.10MP/E —$2.2$7.95
- BDSXBiodesix Inc. Common Stock$23.66▼ 4.25%Market cap $228.86MP/E —$5.26$31.97
- ACHAccendra Health Inc. Common Stock$0.24▼ 7.69%Market cap $223.62MP/E —$0.2615$5.6
- YDESYD Bio Limited Ordinary Shares$5.92▼ 12.17%Market cap $167.45MP/E —$1.7$22
- XGNExagen Inc. Common Stock$7.72▼ 9.81%Market cap $159.64MP/E —$2.59$12.23
- KEQUKewaunee Scientific Corporation Common Stock$32.93▲ 2.30%Market cap $108.73MP/E 11.26$32$46.57
- TLSIWTriSalus Life Sciences Inc. Warrant$0.8799▼ 2.23%Market cap $101.95MP/E —$0.4405$1.85
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| TLSI TriSalus Life Sciences Inc. Common Stock | $299.10M | — | $3.63 | ▼ 6.92% | $2.2$7.95 |
| BDSX Biodesix Inc. Common Stock | $228.86M | — | $23.66 | ▼ 4.25% | $5.26$31.97 |
| ACH Accendra Health Inc. Common Stock | $223.62M | — | $0.24 | ▼ 7.69% | $0.2615$5.6 |
| YDES YD Bio Limited Ordinary Shares | $167.45M | — | $5.92 | ▼ 12.17% | $1.7$22 |
| XGN Exagen Inc. Common Stock | $159.64M | — | $7.72 | ▼ 9.81% | $2.59$12.23 |
| KEQU Kewaunee Scientific Corporation Common Stock | $108.73M | 11.26 | $32.93 | ▲ 2.30% | $32$46.57 |
| TLSIW TriSalus Life Sciences Inc. Warrant | $101.95M | — | $0.8799 | ▼ 2.23% | $0.4405$1.85 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Full Transcript: TriSalus Life Sciences Q2 2026 Earnings Callbenzinga · 10/12/2026
- Unusual volume stocks in Thursday's sessionChartMill · 9/24/2026
- Crude Oil Gains 1%; Cintas Earnings Top ViewsBenzinga · 9/23/2026
- TriSalus Secures FDA Clearance For TriNav Advance as Stock Tests Key SupportBenzinga · 9/23/2026
- TriSalus Life Sciences Shares Rise 15.6% After FDA Clearance for TriNav AdvanceYahoo · 9/23/2026
- TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine And Other Big Stocks Moving Higher On WednesdayBenzinga · 9/23/2026
- Microsoft To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For WednesdayBenzinga · 9/23/2026
- Market-Moving News for September 23rdBenzinga · 9/23/2026
- HC Wainwright & Co. Maintains Buy on TriSalus Life Sciences, Raises Price Target to $12Benzinga · 9/23/2026
Insider Activity
Insider Actions →- Patience David · July 1, 2026 · Tax Withholding14.7K @ $4.46
- Marshak Richard · June 30, 2026 · Grant561 @ $3.87
- Mary T. Szela · June 30, 2026 · Grant4.0K @ $3.87
- Marshak Richard · May 15, 2026 · Sale543 @ $2.67
- Patience David · May 15, 2026 · Buy7.1K @ $2.43
- Gordon Gary B. · May 15, 2026 · Buy10.0K @ $2.46
- Mats Wahlstrom · May 15, 2026 · Buy60.0K @ $2.53
- Stansky Michael P · May 15, 2026 · Buy200.0K @ $2.5
- Stansky Michael P · May 15, 2026 · Buy410.0K @ $2.5
- Mary T. Szela · May 15, 2026 · Buy39.7K @ $2.59
- HICKS KERRY R · May 14, 2026 · Grant56.4K
- HICKS KERRY R · May 14, 2026 · Grant28.2K
- Stansky Michael P · May 14, 2026 · Grant20.1K
- Stansky Michael P · May 14, 2026 · Grant23.5K
- Valle William · May 14, 2026 · Grant28.2K
Institutional Ownership
March 31, 2026
- Total shares held
- 20.41M
- Total value held
- $79.16M
- Institutional holders
- 81
- Unknown5.07M
- Unknown2.08M
- Unknown2.07M
- Unknown1.50M
- Unknown1.44M
- Unknown1.35M
- Unknown888.5K
- Unknown787.3K
- Unknown777.1K
- Unknown583.6K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
TriSalus Stock Rises After FDA Clears TriNav Advance
TriSalus Life Sciences shares climbed 15.6% following FDA clearance for its TriNav Advance product. This regulatory approval marks a significant milestone for the company's pipeline. The stock is currently testing key support levels after the recent price movement.
TriSalus Stock Rises After FDA Clears TriNav Advance. TriSalus Life Sciences shares climbed 15.6% following FDA clearance for its TriNav Advance product. This regulatory approval marks a significant milestone for the company's pipeline. The stock is currently testing key support levels after the recent price movement.